Bharat Explosives

Noida, India Founded: 1998 • Age: 28 yrs
Produces explosives for defence, mining, and pharma, with facilities in India.

About Bharat Explosives

Bharat Explosives is a Healthcare company based in Noida (India) founded in 1998. It produces explosives for defence, mining, and pharma, with facilities in India. It operates on a B2B model in Healthcare, Industrial Goods & Manufacturing, and Energy & Utilities sectors. The company has 27 employees. Its Indian entity Bharat Explosives Limited reported revenue of β‚Ή36.81 Cr. Bharat Explosives offers products and services including Industrial Explosives, High Energy Materials, and Nitroglycerin Drug Substances. Its focus areas include Pharmaceuticals, Drug Substance Manufacturing, Nitroglycerin Variants and Diluted Forms. Similar companies include Airbus, Kratos, QinetiQ, BAE Systems and Lockheed Martin and 5 more; 2 of its 10 listed similar companies have raised funding.

Company details

Bharat Explosives Limited specializes in manufacturing high-energy explosives and fuels for defence and civil applications, including mining explosives. They operate a USFDA-approved pharma facility for Nitroglycerin variants, collaborating with DRDO for indigenous development. Based in Lalitpur and Noida, Uttar Pradesh, India, they supply to mining firms, defence organizations, and pharmaceutical industries, emphasizing safety and RD.

  • Headquarters Noida, India
  • Employees 27
  • Sectors
    Healthcare
    Industrial Goods & Manufacturing Energy & Utilities
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website belindia.co.in
  • Legal Name Bharat Explosives Limited
  • Date of Incorporation 21 Aug, 1962
  • Jurisdiction Lalitpur, Uttar Pradesh, India
Key Metrics
  • Annual Revenue
    ₹36.81 Cr

    FY 2025 · -13% YoY

  • Net Profit
    ₹2.28 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹1.48 Cr

    FY 2025 · 4% margin

  • Employee Count
    27

Products & Services of Bharat Explosives

Bharat Explosives offers a comprehensive portfolio of products and services, including Industrial Explosives, High Energy Materials, and Nitroglycerin Drug Substances.

Industrial Explosives
Mining Products

Explosives for mining and infrastructure sectors.

High Energy Materials
Defence Products

Fuels and materials for defence applications.

Nitroglycerin Drug Substances
Pharma Products

Variants of diluted Nitroglycerin for medical use.

Board of directors of Bharat Explosives Limited (Bharat Explosives)

Bharat Explosives Limited is the primary company behind Bharat Explosives. The board of Bharat Explosives Limited currently have 4 directors; the longest-serving is Rama Kant Ram, appointed in 2006. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rama Kant Ram
DIN 00791154
Managing Director20 Aug 200620 yrs 1 moBharat Explosives Limited
Anoop Singh Patwal
DIN 06414149
Director01 May 201412 yrs 5 moBharat Explosives Limited
Raghu Perandurai Vasudeva Rao
DIN 10189664
Director05 Jun 20233 yrs 4 moBharat Explosives Limited
Vinod Kumar Gupta
DIN 03131506
Director12 Jan 20269 moBharat Explosives Limited

Financials of Bharat Explosives

Figures of Bharat Explosives Limited, the primary company behind Bharat Explosives, for FY 2025. Revenue was ₹36.81 Cr (-13% year on year). Net profit was ₹2.28 Cr (6% margin). EBITDA was ₹1.48 Cr (4% margin). Revenue has grown at a compounded annual rate of -16% over three years and +19% over five years.

  • ₹36.81 CrRevenue · FY 2025 · -13% YoY
  • ₹2.28 CrNet profit · 6% margin
  • ₹1.48 CrEBITDA · 4% margin
  • ₹23.64 CrPaid-up capital
  • 27Employees (provident fund records)
  • -16%Revenue CAGR, 3 years
  • +19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bharat Explosives Limited are on its company page.

Premium access

Detailed financial statements for Bharat Explosives

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Bharat Explosives

Bharat Explosives has 10 listed similar companies in our database, 2 of them funded. They include Airbus, Kratos, QinetiQ, BAE Systems and Lockheed Martin, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
airbus.com1969Toulouse, France–147,893
Commercial aircraft, helicopters, satellites, and launch vehicles are manufactured.
kratosdefense.com1994United States–3,900
AI and cloud-based platforms for national security are provided.
qinetiq.com2001Farnborough, United Kingdom–5,218
Provider of a suite of systems for security solutions
baesystems.com1999United States––
Aerospace and submarine security systems are manufactured by BAE Systems.
lockheedmartin.com1912United States–158
Manufacturer of global security and defense airplanes
l3harris.com1895United States–50,000
Manufacturer of C6ISR system
boeing.com1916United States–23,000
Commercial jetliners, defense, space, and security systems are manufactured.
rtx.com1922United States–36,180
Defense and aerospace systems are manufactured and developed by RTX.
parasdefence.com1972Navi Mumbai, India$4.55M212
A wide range of defence products and solutions is offered.
sncorp.com1963Sparks, United States$61.7M4,515
Diversified space components, subsystems, and spacecraft are manufactured.
Premium access

Detailed similar companies of Bharat Explosives

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Bharat Explosives (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bharat Explosives

Bharat Explosives was founded in 1998.

Bharat Explosives is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

Bharat Explosives has 27 employees.

The primary company behind Bharat Explosives, Bharat Explosives Limited, reported revenue of β‚Ή36.81 Cr for FY 2025, down 13% year on year.

Bharat Explosives Limited specializes in manufacturing high-energy explosives and fuels for defence and civil applications, including mining explosives. They operate a USFDA-approved pharma facility for Nitroglycerin variants, collaborating with DRDO for indigenous development. Based in Lalitpur and Noida, Uttar Pradesh, India, they supply to mining firms, defence organizations, and pharmaceutical industries, emphasizing safety and RD.

Bharat Explosives's top competitors include RTX, Airbus and Lockheed Martin.

Bharat Explosives offers Industrial Explosives, High Energy Materials, and Nitroglycerin Drug Substances.

Bharat Explosives operates through Bharat Explosives Limited.

The legal entities of Bharat Explosives currently have 6 directors, including Rama Kant Ram, Anoop Singh Patwal, Mansi Mamgain and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available